| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-12 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |